Status and prospect of prenatal genetic diagnosis of fetal congenital heart disease

doi:10.3969/j.issn.1674-8115.2022.10.017

Abstract

Abstract:

Congenital heart disease (CHD) is diagnosed as the birth defect that causes heart or blood vessel structure abnormality due to genetic or environmental factors, leading to cardiac dysfunction. It is the most common disease among birth defects in China recently, and its incidence is increasing year by year, seriously affecting the health of newborns, especially for some complicated CHD fetuses. The birth survival rate is very low, and surgical interventions are necessary, which bring heavy psychological and economic burden to the families of fetuses, and seriously affect the aristogenesis and aristogenesis in China. The etiology of CHD is complex. Nowadays, it is believed that the occurrence of CHD is closely related to genetic and environmental factors. Some studies showed that genetic factors were the main causes of CHD, and approximately one of ten fetuses with CHD were related to genetic inheritance. Therefore, prenatal diagnosis to investigate the genetic causes of fetal CHD is crucial for evaluating fetal prognosis. In recent years, more and more studies at home and abroad have focused on the genetic etiology of congenital heart disease. Relevant review articles published in China only focused on the progress of certain genetic testing techniques for the detection of chromosomal abnormalities of CHD, and there is still a lack of comprehensive summary of various prenatal genetic testing techniques on the detection of genetic causes of CHD. This article reviews and prospects various genetic testing techniques for CHD.

Key words: congenital heart disease (CHD), prenatal diagnosis, chromosomal microarray analysis, whole exome sequencing

CLC Number:

R715.5

LI Min, WU Yi, CHENG Weiwei. Status and prospect of prenatal genetic diagnosis of fetal congenital heart disease[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(10): 1498-1503.

TrendMD

References 40

1	ZAIDI S, BRUECKNER M. Genetics and genomics of congenital heart disease[J]. Circ Res, 2017, 120(6): 923-940.
2	PIERPONT M E,BRUECKNER M,CHUNG W K,et al. Genetic basis for congenital heart disease: revisited: a scientific statement from the american heart association[J]. Circulation, 2018, 138(21): e653-e711.
3	HOPKINS M K, DUGOFF L, KULLER J A. Congenital heart disease: prenatal diagnosis and genetic associations[J]. Obstet Gynecol Surv, 2019, 74(8): 497-503.
4	LIU Y J, CHEN S, ZÜHLKE L, et al. Global birth prevalence of congenital heart defects 1970‒2017: updated systematic review and meta-analysis of 260 studies[J]. Int J Epidemiol, 2019, 48(2): 455-463.
5	BOUMA B J, MULDER B J M. Changing landscape of congenital heart disease[J]. Circ Res, 2017, 120(6): 908-922.
6	TREVISAN P, ROSA R F M, KOSHIYAMA D B, et al. Congenital heart disease and chromossomopathies detected by the karyotype[J]. Rev Paul Pediatr, 2014, 32(2): 262-271.
7	郭辉, 林琳华, 任景慧, 等. 产前超声诊断胎儿先天性心脏病中染色体核型异常的分析[J]. 中国优生与遗传杂志, 2014, 22(7): 38-39.
	GUO H, LIN L H, REN J H, et al. Analysis of abnormal chromosome karyotype in the diagnosis of fetal congenital heart disease by prenatal ultrasound[J]. Chinese Journal of Birth Health & Heredity, 2014, 22(7): 38-39.
8	游艳琴, 李亚里. 荧光原位杂交技术在产科相关领域的应用[J]. 国际妇产科学杂志, 2013, 40(5): 420-423.
	YOU Y Q, LI Y L. Application of fluorescence in situ hybridization technology in obstetric-related fields[J]. J Int Obstet Gynecol, 2013, 40(5): 420-423.
9	GOLDMUNTZ E. 22q11.2 deletion syndrome and congenital heart disease[J]. Am J Med Genet C Semin Med Genet, 2020, 184(1): 64-72.
10	赵婧, 黄湘, 李红艳, 等. 荧光原位杂交技术在先天性心脏病产前诊断中的应用[J]. 检验医学与临床, 2015, 12(23): 3512-3514.
	ZHAO J, HUANG X, LI H Y,et al. Application of fluorescence in situ hybridization in prenatal diagnosis of congenital heart disease[J]. Lab Med Clin, 2015, 12(23): 3512-3514.
11	GEDDES G C, BUTTERLY M, SAJAN I. FISH for 22q11.2 deletion not cost-effective for infants with congenital heart disease with microarray[J]. Pediatr Cardiol, 2015, 36(3): 531-536.
12	辛毅, 潘晓冬, 刘晴, 等. 荧光原位杂交技术产前诊断先天性心脏病22q11.2微缺失应用价值[J]. 心肺血管病杂志, 2012, 31(3): 236-240.
	XIN Y, PAN X D, LIU Q, et al. Application value of fluorescence in situ hybridization in prenatal diagnosis of congenital heart disease with 22q11.2 microdeletion[J]. J Cardiovasc Pulm Dis, 2012, 31(3): 236-240.
13	徐志红, 文强, 王秀, 等. 产前全外显子组测序技术的应用进展[J]. 中国优生与遗传杂志, 2020, 28(3): 390-393.
	XU Z H,WEN Q,WANG X,et al. Application progress of prenatal whole exome sequencing technology[J]. Chinese Journal of Birth Health & Heredity, 2020, 28(3): 390-393.
14	汪敏, 赵绍杰, 卢斌, 等. 染色体微阵列分析技术在先天性心脏病胎儿中的临床应用[J]. 现代妇产科进展,2021, 30(2): 133-136, 140.
	WANG M,ZHAO S J,LU B,et al. Clinical application of chromosomal microarray analysis technology in fetuses with congenital heart disease[J]. Progress in Obstetrics and Gynecology, 2021, 30(2): 133-136, 140.
15	LEVY B, WAPNER R. Prenatal diagnosis by chromosomal microarray analysis[J]. Fertil Steril, 2018, 109(2): 201-212.
16	HALDER A, JAIN M, KALSI A K. SNP microarray in FISH negative clinically suspected 22q11.2 microdeletion syndrome[J]. Scientifica, 2016, 2016: 5826431.
17	WANG Y, CAO L, LIANG D, et al. Prenatal chromosomal microarray analysis in fetuses with congenital heart disease: a prospective cohort study[J]. Am J Obstet Gynecol, 2018, 218(2): 244.e1-244.e17.
18	王桂喜, 孙锟, 孔令晖, 等. SNP array分析技术在胎儿先天性心脏病诊断中的价值[J]. 临床儿科杂志, 2021, 39(10): 726-728.
	WANG G X, SUN K, KONG L H, et al. The value of SNP array analysis technology in the diagnosis offetal congenital heart disease[J]. J Clin Pediatr, 2021, 39(10): 726-728.
19	汪敏, 肖建平, 赵丽, 等. 染色体微阵列分析技术在先天性心脏病胎儿遗传病因学诊断中的临床价值[J]. 中国实用妇科与产科杂志, 2022, 38(3): 359-362.
	WANG M, XIAO J P, ZHAO L, et al. Clinical value of chromosomal microarray analysis technology in the diagnosis of fetal genetic etiology of congenital heart disease[J]. Chin J Pract Gynecol Obstet, 2022, 38(3): 359-362.
20	Society for Maternal-Fetal Medicine (SMFM) Electronic Address: pubs@smfm org, DUGOFF L, NORTON M E, et al. The use of chromosomal microarray for prenatal diagnosis[J]. Am J Obstet Gynecol, 2016, 215(4): B2-B9.
21	ARMOUR C M, DOUGAN S D, BROCK J A, et al. Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada[J]. J Med Genet, 2018, 55(4): 215-221.
22	MILLER D T, ADAM M P, ARADHYA S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies[J]. Am J Hum Genet, 2010, 86(5): 749-764.
23	中华医学会医学遗传学分会临床遗传学组, 中国医师协会医学遗传医师分会遗传病产前诊断专业委员会, 中华预防医学会出生缺陷预防与控制专业委员会遗传病防控学组. 低深度全基因组测序技术在产前诊断中的应用专家共识[J]. 中华医学遗传学杂志, 2019, 36(4): 293-296.
	Clinical Genetics Group, Medical Genetics Branch of Chinese Medical Association, Professional Committee of Prenatal Diagnosis of Genetic Diseases, Medical Geneticists Branch of Chinese Medical Doctor Association, Genetic Disease Prevention and Control Group of Birth Defect Prevention and Control Professional Committee of Chinese Preventive Medicine Association. Expert consensus on the application of low-depth whole genome sequencing technology in prenatal diagnosis[J]. Chin J Med Genet, 2019(4): 293-296.
24	李奉瑾, 姚欣雨, 张玉萍. 低深度全基因组测序技术在产前诊断中的研究进展[J]. 国际妇产科学杂志, 2021, 48(1):75-78, 83.
	LI F J,YAO X Y,ZHANG Y P. Research progress of low-depth whole genome sequencing technology in prenatal diagnosis[J]. J Int Obstet Gynecol, 2021, 48(1): 75-78, 83
25	ZHU XY, LI J, RU T, et al. Identification of copy number variations associated with congenital heart disease by chromosomal microarray analysis and next-generation sequencing[J]. Prenat Diagn, 2016, 36(4): 321-327.
26	邓新娥, 黄杏玲, 王远流, 等. 拷贝数变异测序在胎儿先天性心脏病产前遗传学诊断中的应用[J]. 中国生育健康杂志, 2020, 31(2): 137-142.
	DENG X E,HUANG X L,WANG Y L,et al. Application of copy number variation sequencing in prenatal genetic diagnosis of fetal congenital heart disease[J]. Chinese Journal of Reproductive Health,2020, 31(2): 137-142.
27	LAN L B, SHE L N, ZHANG B S, et al. Prenatal diagnosis of 913 fetuses samples using copy number variation sequencing[J]. J Gene Med, 2021, 23(5): e3324. .
28	LI R, FU F, YU Q X, et al. Prenatal exome sequencing in fetuses with congenital heart defects[J]. Clin Genet, 2020, 98(3): 215-230.
29	QIAO F, WANG Y, ZHANG C, et al. Comprehensive evaluation of genetic variants using chromosomal microarray analysis and exome sequencing in fetuses with congenital heart defect[J]. Ultrasound Obstet Gynecol, 2021, 58(3): 377-387.
30	LORD J, MCMULLAN D J, EBERHARDT R Y, et al. Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study[J]. Lancet, 2019, 393(10173): 747-757.
31	PETROVSKI S, AGGARWAL V, GIORDANO J L, et al. Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study[J]. Lancet, 2019, 393(10173): 758-767.
32	FU F, LI L S, DU K, et al. Analysis of families with fetal congenital abnormalities but negative prenatal diagnosis by whole exome sequencing[J]. Zhonghua Fu Chan Ke Za Zhi, 2021, 56(7): 458-466.
33	MONAGHAN K G, LEACH N T, PEKAREK D, et al. The use of fetal exome sequencing in prenatal diagnosis: a points to consider document of the American College of Medical Genetics and Genomics (ACMG)[J]. Genet Med, 2020, 22(4): 675-680.
34	DUEÑAS A, EXPÓSITO A, ARANEGA A, et al. The role of non-coding RNA in congenital heart diseases[J]. J Cardiovasc Dev Dis, 2019, 6(2): 15.
35	YANG H N, YANG S P, SHEN H L, et al. Construction of the amniotic fluid-derived exosomal CeRNA network associated with ventricular septal defect[J]. Genomics, 2021, 113(6): 4293-4302.
36	DUEÑAS A, EXPÓSITO A, ARANEGA A, et al. The role of non-coding RNA in congenital heart diseases[J]. J Cardiovasc Dev Dis, 2019, 6(2): 15.
37	WANG Z, QIAO X H, XU Y J, et al. SMAD1 loss-of-function variant responsible for congenital heart disease[J]. Biomed Res Int, 2022, 2022: 9916325.
38	顾卉, 陈骊珠, 薛佳, 等. 先天性心脏病胎儿母体血清中的microRNA表达谱及其诊断意义[J]. 发育医学电子杂志, 2019, 7(1): 32-37.
	GU H,CHEN L Z,XUE J,et al. MicroRNA expression profile in maternal serum of fetuses with congenital heart disease and its diagnostic significance[J]. Journal Developmental Medicine (Electronic Version), 2019, 7(1): 32-37.
39	杨伟, 王峥. 超声心动检查联合孕妇血清miRNA-19b、AFP测定对胎儿先天性心脏病的诊断价值分析[J]. 中国优生与遗传杂志, 2020, 28(5): 618-621.
	YANG W,WANG Z. Analysis of the diagnostic value of echocardiography combined with maternal serum miRNA-19b and AFP determination in fetal congenital heart disease[J]. Chinese Journal of Birth Health & Heredity, 2020, 28(5): 618-21.
40	金玉霞, 李素萍, 艾玲, 等. 孕妇血清中miRNAs作为生物标志物用于胎儿先心病法洛四联症的产前检测[J]. 中国卫生检验杂志, 2021, 31(16): 1931-1934, 1939.
	JIN Y X, LI S P, AI L,et al. Prenatal detection of fetal congenital heart disease tetralogy of Fallot with miRNAs in maternal serum as biomarkers[J]. Chinese Journal of Health Laboratory Technology, 2021, 31(16): 1931-1934, 1939.

[1]	WANG Peng-peng, ZHU Xiao-dong, XIE Wei. Analysis of clinical features and prognostic factors of meconium peritonitis [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(5): 662-665.
[2]	Maerziya YUSUFUJIANG1, LUO Fei1, LIU Yu2,3, DONG Yuan-yuan1, XU Gang1, ZHOU Xin-yi1, JIN Ping1, LI Na1. Survey on cognition, attitude, willingness and demand for non-invasive prenatal testing among pregnant women [J]. , 2019, 39(6): 648-.
[3]	ZHAO Xin-rong, WANG Yan-lin, FAN Yang-yang, GAO Li. Clinical consultation and prognosis analysis of fetus with increased nuchal translucency [J]. , 2018, 38(5): 529-.
[4]	ZHANG Sen, CAI Mei-hua, HE Pan, ZHANG Rui-dong, HUANG Yue, ZHENG Ji-jian. Assessment of safety about therapeutic cardiac catheterization in congenital heart disease children with recent upper respiratory tract infection [J]. , 2018, 38(4): 422-.
[5]	ZHAO Li-qing, SUN Kun. Detection rate and associated influencing factors for fetal congenital heart diseases diagnosed with prenatal echocardiography [J]. , 2016, 36(6): 930-.
[6]	XIE Jing, SUN Kun. Advances of diagnosis and catheter intervention of pulmonary atresia with intact ventricular septum [J]. , 2014, 34(5): 759-.
[7]	SUN Wei, SHEN Jia-wei, LONG Fei, et al. Selection of short tandem repeats and their application in linkage analysis for prenatal diagnosis of spinal muscular atrophy [J]. , 2010, 30(6): 707-.
[8]	JIANG Wen-ting, LONG Fei, NI Lin, et al. Application of fluorescence in situ hybridization in prenatal diagnosis of chromosome abnormalities [J]. , 2010, 30(5): 604-.